RVTY · Revvity, Inc.
$158.77
+0.94% last session
End-of-day data · close of 2026-10-23
Market cap
$18B
Enterprise value
$20B
Trailing P/E
76.0
Forward P/E
26.9
Dividend yield
0.0%
Beta
1.06
Avg volume
2M
Employees
11K
Daily Change %
0.94%
5 Days Change
3.09%
10 Days Change
1.47%
30 Days Change
10.73%
60 Days Change
27.93%
Month to Day Change
5.57%
Year to Day Change
62.97%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — RVTY
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-13
Latest call per bank · past 12 months
Barclays
Equal-Weight$160
+0.8% vs priceRBC Capital
Sector Perform$135
-15.0% vs priceJP Morgan
Neutral$90.00
-43.3% vs priceGoldman Sachs
Neutral$95.00
-40.2% vs priceWells Fargo
Equal-Weight$110
-30.7% vs priceJefferies
Hold$105
-33.9% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-13 | TD Cowen | Maintains | Buy | $130 → $175 |
| 2026-10-07 | Barclays | Maintains | Equal-Weight | $115 → $160 |
| 2026-10-06 | William Blair | Initiates | Outperform | $0.00 |
| 2026-09-04 | Keybanc | Maintains | Overweight | $125 → $165 |
| 2026-09-01 | RBC Capital | Initiates | Sector Perform | $0.00 → $135 |
| 2026-08-05 | Evercore ISI Group | Maintains | Outperform | $125 → $126 |
| 2026-07-06 | Evercore ISI Group | Maintains | Outperform | $110 → $125 |
| 2026-05-07 | Barclays | Maintains | Equal-Weight | $95.00 → $105 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-23
- neutral: RSI (14): RSI is 66 — neutral momentum, neither overbought nor oversold.
- bullish: Price vs 50-day MA: Trading 13.4% above the 50-day MA ($140.02).
- bullish: Price vs 200-day MA: Trading 43.9% above the 200-day MA ($110.37).
- bullish: MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- bearish: MACD (12,26,9): MACD histogram is negative (-0.51) — short-term momentum is fading.
- bullish: 52-week range: Price is within 5% of the 52-week high ($158.77).
RVTY Price Chart
Loading chart for RVTY…
Fundamentals
About Revvity, Inc.
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, and training and services; and instruments, reagents, and assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. It also develops technologies that enable and support genomic workflows using protein coupled receptors and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
More in Diagnostics & Research
TMO
Thermo Fisher Scientific Inc
$249B 17.1% YTD
DHR
Danaher Corporation
$162B 1.0% YTD
NTRA
Natera, Inc.
$58B 75.2% YTD
A
Agilent Technologies, Inc.
$49B 28.7% YTD
IQV
IQVIA Holdings, Inc.
$46B 23.5% YTD
WAT
Waters Corporation
$45B 20.0% YTD
IDXX
IDEXX Laboratories, Inc.
$44B -16.2% YTD
ILMN
Illumina, Inc.
$41B 105.4% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.